PhysIQ Adds NorthShore University HealthSystem to COVID-19 Digital Biomarker Study
NorthShore University HealthSystem (NorthShore) has joined physIQ s NIH-funded DeCODe study to develop an AI-based COVID-19 digital biomarker.
- NorthShore University HealthSystem (NorthShore) has joined physIQ s NIH-funded DeCODe study to develop an AI-based COVID-19 digital biomarker.
- NorthShore will serve as an enrollment center and key partner in the Phase II validation stage of this study.
- Using continuous multi-parameter vital signs and physiological features, we hope to support physIQ in establishing a targeted COVID-19 digital biomarker to help detect worsening patients.
- Adding NorthShore as a site brings new dimension to the study that will be extremely valuable to the study outcomes.